Vaccine rollout ‘relied on GP goodwill’: Study General practices involved in Australia’s COVID-19 vaccination program struggled to make ends meet, researchers say.
TGA approves Omicron-specific vaccine The ‘bivalent’ COVID-19 vaccine, developed by Moderna, has been given the go-ahead by the Australian medicines regulator.
First country approves Moderna vaccine targeting Omicron The approval comes in the same week that Monash University was selected to house the first mRNA production facility in the Southern Hemisphere.
ATAGI approves Moderna vaccine for at-risk young children Parents are advised not to contact vaccine providers until bookings open, following decision to approve vaccination for the youngest cohort.
Short EOI window for paediatric COVID shots Expressions of interest for the six-month to four-year-old cohort are now being accepted, but general practices only have until Friday to nominate.
Slight rise in adverse reactions for joint COVID and flu jabs A peer-reviewed article looking at the co-administration of COVID booster and flu vaccines in the US reports that most reactions tend to be mild.
Supply issues flagged as TGA provisionally approves Moderna for under-fives The Federal Health Minister has urged parents to delay booking COVID vaccine appointments for their very young children.
Second application pending for under-fives COVID vaccine Pfizer has been told it can apply for its Comirnaty vaccine to be used to immunise children under five in Australia.
TGA releases vaccine-related myocarditis severity details Fewer than 1% of all likely myocarditis or pericarditis cases linked to mRNA vaccines in Australia have been treated in intensive care.
Extra booster dose recommended by ATAGI The rollout of additional COVID-19 vaccine doses for those ‘at greatest risk of severe illness’ will commence ahead of winter to tie in with flu vaccination.